David Smith, DPM | |
1159 W Jefferson St Ste 204, Franklin, IN 46131-2795 | |
(317) 346-7722 | |
(317) 346-7725 |
Full Name | David Smith |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 7 Years |
Location | 1159 W Jefferson St Ste 204, Franklin, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952835183 | NPI | - | NPPES |
07001348A | Other | LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 07001348A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Indiana University Health Tipton Hospital Inc | Tipton, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Upperline Healthcare Pc | 4385900653 | 117 |
News Archive
People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 7 days ago
Provider Name | Hoosier Foot And Ankle Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1942492814 PECOS PAC ID: 8820074750 Enrollment ID: O20060308000696 |
News Archive
People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 7 days ago
Provider Name | Upperline Healthcare Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1538686498 PECOS PAC ID: 4385900653 Enrollment ID: O20210723001347 |
News Archive
People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
David Smith, DPM 12507 Wolford Dr, Fishers, IN 46038-1256 Ph: () - | David Smith, DPM 1159 W Jefferson St Ste 204, Franklin, IN 46131-2795 Ph: (317) 346-7722 |
News Archive
People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
RegeneRx Biopharmaceuticals, Inc. announced today that the Company has been included on MDB Capital Group's "Best & Brightest" innovators list of 150 companies for 2011. Criterion for inclusion is a ranking in the 90th percentile for technology leadership from more than 1,500 companies with U.S. patents granted, as rated by PatentVest®, MDB's proprietary, intellectual property (IP), business intelligence database.
› Verified 7 days ago
Dr. Anthony D. Jagger, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1159 W Jefferson St Ste 204, Franklin, IN 46131 Phone: 317-346-7722 Fax: 317-346-7725 | |
Dr. Joshua Clay Fisher, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1125 W Jefferson St, Franklin, IN 46131 Phone: 317-736-3300 | |
Christine Dhiman Bhinder, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1159 W Jefferson St Ste 204, Franklin, IN 46131 Phone: 317-346-7722 Fax: 317-346-7725 | |
Mrs. Farwa Abid-hoffman, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1159 W Jefferson St Ste 204, Franklin, IN 46131 Phone: 317-346-7722 Fax: 317-346-7725 | |
Indiana Foot & Ankle Surgeons Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1159 W Jefferson St, Suite 204, Franklin, IN 46131 Phone: 317-346-7722 | |
Hoosier Foot And Ankle Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1159 W Jefferson St Ste 204, Franklin, IN 46131 Phone: 317-346-7722 Fax: 317-346-7725 |